I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Fisher Center Discovery Program
To develop excellence in clinical research regarding environmental infectious pathogens, the Center has created the Fisher Center Discovery Program (FCDP). Goals of the FCDP include:
- Funding of grants for clinical research related to environmental infectious diseases
- Provision of resources for studies that lack traditional funding mechanisms
- Promotion of cross-disciplinary collaborative research
- Provision of mentoring opportunities for early career investigators
We award a maximum of $50,000 to individual researchers during a single annual grant cycle. Notifications about the grants opportunity are distributed by email via individual schools of the Johns Hopkins University and pertinent faculty list serves. All full-time faculty members of the Johns Hopkins University, especially junior faculty, are encouraged to apply. For questions concerning the grants program, please email firstname.lastname@example.org or call 443-287-4840.
2018 Fisher Center Discovery Program Grant Cycle
The 2018 application space is now open. Click on the name of the document for a hyperlink to that document.
|Full Application||PDF fillable form||September 18, 2017|
|Application Guidelines||PDF read-only document|
|Frequently Asked Questions||PDF read-only document|
|Letter of Intent Form||PDF fillable form||August 21, 2017|
|Budget Template||Excel document||September 18, 2017|
Submit the Letter of Intent, application, and supporting documents via email, email@example.com
Questions? Contact firstname.lastname@example.org or 443-287-4840.
|Prior Awards: Project Title||Award Year||Principal Investigator, Johns Hopkins University|
|Development and Clinical Evaluation of Laboratory Methods to Identify Reduced Antiseptic Susceptibility in Organisms Causing Healthcare Associated Infections||2013||Aaron Milstone, M.D., M.H.S|
|Detection of Unrecognized Tick-borne Febrile illness in the Upper Midwest and Northeast United States||2013||Megan Reller, M.D., M.P.H.|
|Clostridium difficile: Impact of colonization versus transmission on development of infection||2013||Trish Perl, M.D.|
|Does Disruption of Host Microbiota Modify Colorectal Cancer Risk?||2013||Cynthia Sears, M.D.|
|Evolutionary dynamics of multidrug-resistant Staphylococcus aureus (MDRSA), a zoonotic pathogen of clinical significance, among industrial food animal production workers||2013||Christopher Heaney, Ph.D.|
|An evidence-based screening approach to identify children at high risk for harboring multi-drug resistant Gram-negative organisms in the PICU||2014||Pranita Tamma, M.D., M.H.S.|
|Home Environmental Exposure to Staphylococcal Bacteria and Asthma Exacerbation||2014||Elizabeth Matsui, M.D., M.H.S.|
|Identifying Environmental Transmission Routes for Shigellosis in Rural Settings using Pulsed-field Gel Electrophoresis||2014||Christine George, Ph.D.|
|Immune Events in Human Lyme Disease||2014||Mark Soloski, Ph.D.|
|Characterization of β-lactam Resistance in Enterobacteriaceae Isolated from the Chesapeake Bay and Upper Watershed||2014||Nicole Parrish, Ph.D.|
|Host Genetic Susceptibility to Cryptosporidia Infection||2014||Priya Duggal, Ph.D., M.P.H|
|Diagnostics for latent histoplasmosis||2015||Kieren Marr, M.D.|
|The Home Environment: Infections among Patients Discharged Home with Venous Catheters||2015||Trish Perl, M.D.|
|Salivary diagnostics for pathogens of clinical significance in childhood environmental enteropathy||2015||Margaret Kosek, M.D.|
|Identifying molecular targets for preventing multidrug tolerance in Mycobacterium avium infection||2016||Petros Karakousis, M.D.|
|The role of nsP3 in neurovirulence of chikungunya virus||2016||Diane Griffin, M.D., Ph.D.|
|Molecular Epidemiology of Carbapenem Resistant Gram-Negative Organisms (CROs) at Johns Hopkins Hospital: Do Patients Infected with CROs Contaminate the Hospital Room Environment?||2016||Patricia Simner, Ph.D.|
|High-density poultry operations and associated infectious disease risks||2016||Brian Schwartz, M.D., M.S.|
|Building a baseline for assessing the human health impact of a landmark legislative intervention on antibiotic use in industrial poultry production||2017||Keeve Nachman, PhD|
|Identification of early detection biomarkers and candidate therapeutics for congenital Zika virus infection||2017||Sabra L. Klein, PhD|
|African BAOBAB (Babesia Observational Antibody) Study||2017||Evan Bloch, MD|
|Impact of Heterogeneous Resistance Mechanisms on Hospital Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE)||2017||Aaron Milstone, MD|